Studies in experimental models have implicated histamine and prostanoids in ultra-violet B ( UVB)-and cis-urocanic acid ( UCA)-induced systemic immunosuppression. This study examined the hypothesis that UVB irradiation and cis-UCA suppressed contact hypersensitivity responses to hapten by induction of histamine, which in turn evoked a prostanoid-dependent component of immunosuppression. BALB/c mice were administered with a cis-UCA monoclonal antibody, a combination of histamine types 1 and 2 receptor antagonists, or indomethacin. Mice were sensitized to 2,4,6-trinitrochlorobenzene (TNCB) on their ventral surface 5 days after UVB irradiation, or cis-UCA or histamine administration. Ears were challenged with TNCB 5 days later. Cis-UCA antibody inhibited the suppressive eÂects of UVB by approximately 60% and confirmed that suppression of contact hypersensitivity responses by UVB was due, at least in part, to mechanisms involving cis-UCA. Histamine suppressed contact hypersensitivity responses and the eÂects of cis-UCA and histamine were not cumulative, suggesting that cis-UCA and histamine signal largely through the same pathway. The immunosuppressive eÂects of histamine were not aÂected by the cis-UCA antibody, consistent with the model that histamine acts downstream of cis-UCA. Administration of histamine receptor antagonists and indomethacin each approximately halved the UVB-and cis-UCA-induced systemic suppression of contact hypersensitivity responses. The eÂects of the reagents that inhibited the action of histamine and prevented prostanoid production were not cumulative, and suggested involvement in the same pathway. These results support the involvement of cis-UCA, histamine and prostanoids, in a sequence, in UVB-induced systemic suppression of contact hypersensitivity responses.
INTRODUCTION
which, in turn, initiates immunosuppressive signals. There is some evidence that DNA may be a UVB photoreceptor,6,7 Ultra-violet B ( UVB) irradiation (wavelength 280-320 nm) is but trans-urocanic acid (deaminated histidine), a molecular immunosuppressive and allows the growth of highly antigenic species located superficially in the stratum corneum of the skin UV-induced tumours.1,2 The immunosuppression can be both and which isomerizes to its cis form on UVB irradiation, has local and systemic, and results in reduced expression of contact also been implicated in the mechanisms whereby UV hypersensitivity (CHS) and delayed-type hypersensitivity irradiation generates systemic immunosuppression.8-12 Skin ( DTH) responses to a variety of antigens in mice and humans.
painting or parenteral inoculation with cis-UCA can reduce Examination of the suppression of CHS responses to haptens systemic CHS responses and is associated with an alteration in experimental animals has allowed some dissection of the in antigen-presenting cell ability in vivo. However, in vitro mechanisms of the UVB-induced eÂects. [2] [3] [4] studies have shown that the defect is not due to the direct As less than 10% of UVB irradiation reaches the dermis, 5 eÂect of cis-UCA on antigen-presenting cells of the spleen.8 It it seems likely that a UVB photoreceptor exists in the epidermis is generally hypothesized that UVB (and cis-UCA) regulates signficant UVB-induced production of prostaglandin E 2 irradiation ( 18 kJ/m2/mouse), 50 ml of a commercial alcoholbased SPF 15+sunscreen (containing 4-tertiary-butyl-( PGE 2 ), 6-keto PGF 1 a and PGF 2 a. 17 We found that cis-UCA was not stimulatory for PGE 2 production by keratinocytes in 4-methoxy dibenzoyl methane, 2-ethyl-hexyl-paramethoxy cinnamate and 2-hydroxy-4-methoxy-benzophenone) was evenly culture, but synergized with histamine for increased PGE 2 production.16 Furthermore, cis-UCA, but not trans-UCA, applied to the shaved dorsal area of each mouse. The sunscreen components had maximum absorption at 358, 311 and 325 nm, could increase the sensitivity of keratinocytes to very low concentrations of histamine.16 These studies implicated histarespectively.22 The sunscreen inhibited the acute skin damage induced by UV irradiation but minimally reduced the suppresmine as another important mediator in UVB-and cis-UCAinduced systemic immunosuppression.
sion of CHS responses in UVB-irradiated mice. In nine previous experiments in which this sunscreen was applied to The hypothesis to be tested was that the immunomodulatory eÂects of UVB were due, at least in part, to the activity the backs of mice and UVB-irradiated (18 kJ/m2), the CHS response was reduced by 42±9% (mean±SD). In five previous of cis-UCA and that histamine was involved in the biological eÂect of cis-UCA. Finally, the eÂects of UVB, cis-UCA and experiments in the absence of sunscreen,16 the CHS response was reduced by 50±6%. histamine were manifest by increased prostanoid production by, for example, cells of the skin. The eÂects of inhibitors of the activity of cis-UCA and histamine, and the production of Urocanic acid and histamine The trans isomer of UCA was purchased from Sigma Chemical prostanoids, were examined in a murine model of UVBinduced systemic immunosuppression in which the sensitizCo. (St Louis, MO) and UV-irradiated. Cis-UCA was purified from irradiated trans-UCA by ion-exchange chroation phase involved hapten application to a non-irradiated site 5 days after irradiation. The immunosuppressive eÂects of matography.23 For experimentation, both isomers were dissolved in mouse-osmolality-phosphate-buÂered saline ( PBS) UVB were compared directly with those of cis-UCA, and similarly the eÂects of cis-UCA were compared with those of (330 mOsm/kg H 2 O) at 1 mg/ml. For the animal experiments, 0·2-200 mg was injected subcutaneously (s.c.) into the backs histamine. Using the same cis-UCA antibody, both positive18 and negative19,20 involvement of cis-UCA in UVB-induced of mice (control mice received an equal volume of PBS ), 5 days prior to induction of CHS. Histamine (0·2-200 mg/mouse) suppression of CHS responses has been reported recently. Previous investigations of the eÂect of histamine receptor (Sigma) was administered in an identical manner to that described for cis-UCA. antagonists on UVB-and cis-UCA-induced immunosuppression21 had been performed with the hypothesis that cis-UCA may act through receptors for histamine. The studies presented
Injection of the cis-UCA antibody The production of the monoclonal antibody to cis-UCA has herein support the involvement of cis-UCA in UVB-induced systemic suppression of CHS responses, and the involvement been described elsewhere24 and was used as previously optimized.19 Mice were injected intraperitoneally (i.p.) with 300 ml of histamine in the prostanoid-associated component of UVBand cis-UCA-induced immunosuppression.
of 1/500 dilution of the cis-UCA antibody ascitic fluid (equivalent to 0·1 mg IgGl ) 4 h prior to UVB irradiation or cis-UCA administration. As controls, an equal number of mice was MATERIALS AND METHODS injected with 300 ml mouse-osmolality PBS or with PBS containing 0·1 mg X63, a non-specific isotype-matched control Mice Pathogen-free female BALB/c mice, aged [8] [9] [10] [11] [12] In preliminary studies, neither cyproheptadine or cimetidine, at 320 nm). A PVC plastic film was used to screen out wavelengths <290 nm. The dose rate was monitored using a UVX the doses defined above, alone consistently reversed UVBinduced systemic suppression of CHS responses. Thus, the radiometer with a UVX-31 sensor ( Ultraviolet Products Inc., San Gabriel, CA).
combination of an H1 with an H2 receptor antagonist, which was shown in preliminary studies to inhibit UVB-induced For irradiation of the mice, a uniform dorsal area ( 8 cm2) was clean-shaven, the ears protected with black adhesive immunosuppression consistently (data not shown but illustrated in Fig. 4b ), was administered. insulation tape and the mice housed in individual compartments of perspex cages. The sunlamps were held 20 cm above the cages. Mice were UVB-irradiated 5 days prior to induction Indomethacin Pellets containing 0·05 mg indomethacin in a biodegradable of CHS.
In the mice irradiated and administered the histamine carrier ( Innovative Research of America, Toledo, OH) were implanted into mice s.c., by trochar, at the base of the neck3,27 receptor antagonists or indomethacin, immediately before 4 days prior to UVB exposure. The pellets released indomethacin at a constant rate (2·4 mg/day) over a 21-day period. Previous studies have shown that a daily dose of 1·25-2·5 mg indomethacin blocks prostaglandin synthesis.3 Placebo pellets contained the biodegradable carrier alone. There was no evidence of gastrointestinal bleeding in mice receiving the indomethacin pellets.
Assay of CHS
Mice (five animals/group) were sensitized on the shaved ventral skin with 100 ml freshly prepared 5% (w/v) 2,4,6-trinitrochlorobenzene ( TNCB, Tokyo Kasei Kogyo Co. (3) 2(4) 20(7) 200(5) (a) (b)
Cis
Ltd., Tokyo, Japan) in acetone. Five days later, and after by subtracting the ear thickness before challenge. From this value was subtracted the mean swelling measured in mice that were challenged, but not sensitized, with TNCB ( 0·03 mm).
Expression of results and statistical analysis
For each in vivo study, the mean values±SD for changes in the ear thickness upon challenge with TNCB for all five mice in a group were calculated. For some treatments, the mean results from individual studies was used to calculate the mean value±SD for n experiments. Within an experiment, a multiple comparison procedure employing a one-way analysis of variance and Fisher's test was used to determine the statistical significance of diÂerences between experimental and control groups. For comparison of mean values from multiple experiments, a paired Student's t-test was used. Probabilities less than 0·05 were considered significant. those with UVB irradiation, 0·1 mg cis-UCA antibody or the control antibody, X63, was administered 4 h before UVB irradiation (18 kJ/m2) in each of four experiments ( Fig. 2 ) . It was first demonstrated that the eÂect of injecting X63 was not unirradiated animals pre-treated with the same antibody. The specificity of the antibody was confirmed in three experiments diÂerent from injecting an equal volume of PBS (data not shown). UVB was found to suppress the CHS response in in which mice were administered 20 mg cis-UCA s.c. in place of UVB irradiation 4 h after cis-UCA antibody (Fig. 2 ) . In mice pre-treated with X63 by a mean of 52%. The suppression was reduced to 20% in mice pre-treated with the antibody to mice pre-treated with X63, cis-UCA administration caused a 46% suppression of the CHS response. Administration of the cis-UCA, and this change in the CHS response induced by administration of the cis-UCA antibody was significant (P= cis-UCA antibody changed this to 19% suppression of the CHS response (P=0·05). In contrast, in two separate experi-0·02). In one of the experiments, the cis-UCA antibody totally blocked the suppressive eÂects of UVB irradiation. Indeed, ments, administration of the cis-UCA antibody had no eÂect on the suppressive properties of histamine ( Fig. 2) . when the results of the four experiments were combined, the CHS response of UVB irradiated mice pre-treated with the That cis-UCA and histamine may signal systemic immunosuppression by similar pathways is suggested by the lack of cis-UCA antibody was not significantly diÂerent from that of (Fig. 3 ) .
(b) an asterisk represents a significant diÂerence in the ear swelling by the UVB-irradiated or cis-UCA-administered mice that were administered the histamine receptor antagonists ( HRantag) and both
The eÂect of histamine receptor antagonists on UVB-and To investigate the role of histamine in UVB-and cis-UCA-induced suppression of contact hypersensitivity to TNCB, cyproheptadine, 330 mg/mouse/day, with cimetidine 100 mg/mouse/day, were administered to BALB/c mice on each of four consecutive days, namely days −1, 0, +1 and +2 of UVB irradiation (18 kJ/m2). This dosage of histamine receptor antagonists on days −1, 0, +1 and +2 of s.c. administration of histamine was suÃciently potent to inhibit by 77% the eÂects of 200 mg histamine (Fig. 4a) . The histamine receptor antagonists had no significant eÂect on CHS responses in nonirradiated mice (Fig. 4b) . The inhibitory eÂects on UVBinduced suppression of CHS responses of the combination of an H1 with an H2 receptor antagonist were significant in each of the five experiments ( Fig. 4b) . However, the response by irradiated, receptor-antagonist-treated mice was significantly less than that measured in non-irradiated receptor-antagonisttreated mice, indicating that the reversal of immunosuppres- ( Fig. 4b) .
was assessed commencing 5 days after UVB irradiation or cis-UCA administration. Ear swelling in each experiment was normalized,
The eÂect of indomethacin on UVB-and cis-UCA-induced with the swelling of control mice calculated as 100%. The mean swelling+SD for mice from six and nine experiments, respectively, is systemic suppression of CHS responses
shown. An asterisk represents a significant diÂerence in the ear swelling The eÂect of indomethacin or placebo pellets administered 4 by the UVB-irradiated or cis-UCA-administered mice that were admindays prior to UVB irradiation or cis-UCA administration is . The eÂect of indomethacin on the immunosuppression (cm; 100 mg/mouse/day) were injected into animals on each of four induced by cis-UCA, histamine, and cis-UCA with histamine. consecutive days, starting from one day prior to (a) UVB irradiation Indomethacin or placebo pellets were implanted s.c. into mice (five ( 18 kJ/m2), and (b) cis-UCA administration (200 mg). Indomethacin animals/group) 4 days prior to s.c. injection of 200 mg of cis-UCA, (indo) or placebo pellets were implanted s.c. into mice 4 days prior to 200 mg histamine or cis-UCA with histamine, or an equal volume of UVB irradiation or cis-UCA administration. The CHS response to diluent (control ). The CHS response to TNCB was assessed commenc-TNCB was assessed commencing 5 days after UVB irradiation or cising 5 days after injection of cis-UCA, histamine or cis-UCA with UCA administration. In (a) the mean ear swelling+SD for three histamine. The mean ear swelling+SD for five mice in each group is experiments is shown. In (b) the mean ear swelling for five mice per
shown. An asterisk represents a significant diÂerence in the ear swelling group+SD in a single experiment is shown. An asterisk represents a by the indomethacin-treated, cis-UCA-, histamine-or cis-UCA with significant diÂerence in the ear swelling by the UVB-irradiated or cishistamine-treated mice and both (a) those administered indomethacin UCA-administered mice that were administered the antagonists and/or alone, and ( b) those treated with cis-UCA, histamine or cis-UCA indomethacin and both (a) those UVB-irradiated or administered ciswith histamine. UCA, and ( b) those non-irradiated but administered the antagonists and/or indomethacin.
The eÂect of indomethacin on the systemic suppression of CHS responses caused by histamine or cis-UCA, alone or in significant, partial reversal of UVB-and cis-UCA-induced combination suppression of CHS responses.
Both histamine and cis-UCA (200 mg/mouse) suppressed CHS responses by an extent similar to that caused by the The eÂect of histamine receptor antagonists with indomethacin co-administration of both reagents ( Fig. 3) . The partial reveron UVB-and cis-UCA-induced suppression of CHS responses sal of the immunosuppression by indomethacin was similar in all treatment groups; Fig. 7 shows the eÂects of indomethacin The cumulative inhibitory eÂects of histamine receptor antagonists (cyproheptadine with cimetidine) and indomethacin on on the mice of the second experiment of Fig. 3 . UVB-and cis-UCA-induced immunosuppression were investigated in three and two experiments, respectively. For the three DISCUSSION experiments summarized in Fig. 6a , UVB irradiation reduced ear swelling by 41% (P=0·02). Both cimetidine with cyprohepMany studies have implicated cis-UCA in the mechanisms by which UVB suppresses CHS responses in mice (reviewed in tadine, and indomethacin, significantly increased the CHS responses in UVB-irradiated mice (to 84% of the control refs. 9, 28 ). However, in this study of systemic suppression of CHS responses by UVB irradiation and cis-UCA, it was response, P=0·05, and 80% of the control response, P=0·02, respectively). However, the combination of all three drugs did important to validate this hypothesis and verify that by studying the actions of cis-UCA, we were investigating, at not further reverse the eÂect of UVB irradiation, the CHS response in this group being 77% of, and significantly diÂerent least in part, the mechanisms of action of UVB irradiation. A monoclonal antibody to cis-UCA19,24 was used to confirm to, the control response (P=0·04). In Fig. 6b , the lack of a significant cumulative eÂect of the histamine receptor antagonthat UVB-induced suppression of CHS responses was due, at least in part, to mechanisms involving cis-UCA. The change ists and indomethacin on cis-UCA-induced suppression of CHS responses is shown for a representative of two experiin UVB-induced eÂects on CHS responses from 52% to 20% suppression in mice pretreated with the cis-UCA antibody ments. Thus, there was a significant partial reversal of UVBand cis-UCA-induced immunosuppression by the histamine could be considered a minimum, as a single intraperitoneal injection of the antibody was given 4 h prior to UVB receptor antagonists. A similar reversal was detected following administration of indomethacin. However, there was no irradiation. It is unknown how much of the antibody reached the epidermis, the site of cis-UCA formation. We also do not cumulative eÂect of the histamine receptor antagonists and indomethacin, consistent with a direct relationship between know the half-life of the antibody. It should be noted that the dose of antibody administered also reversed the suppressive histamine and its action, and prostanoid production. activity of 20 mg cis-UCA to a similar extent ( Fig. 2) .
antagonists successfully blocked approximately 80% of the Outcomes of previous studies using this antibody have varied, action of 200 mg histamine administered subcutaneously. with one study using C57BL/6 mice implicating cis-UCA in Optimization of the eÂects of indomethacin were investigated UVB-suppression of CHS responses.18 The other studies19,20 in a previous study;16 both one and two pellets of indomethacin concluded that this antibody reversed UVB-induced changes (releasing 2·4 and 4·8 mg/day, respectively) blocked UVB-and to DTH responses but not CHS responses, but this may reflect cis-UCA-induced suppression of CHS responses by approxithe species of mice used previously (C3H/HeN ) or the availmately 50%. The experiments with the histamine receptor ability of the antibody at the epidermis at a crucial time of antagonists suggested that a significant proportion of the cis-UCA activity. In one study,20 an amount of cis-UCA response due to cis-UCA was attributable to the actions of antibody nine times that used in the present study was histamine. CHS responses were not diÂerent in mice treated administered to each mouse. We have found blocking eÂects with relatively high doses of cis-UCA and histamine and those of the cis-UCA antibody similar to those shown in the present administered histamine alone and, thus, did not provide study (which examined systemic CHS responses in BALB/c evidence for a histamine-independent component of cis-UCAmice) on UVB suppression of local CHS responses in BALB/c induced immunosuppression. Indomethacin was able to reverse mice, and on systemic CHS responses in C57BL/6J mice only partially the immunosuppressive properties of histamine, receiving 2 kJ/m2 UVB (data not shown).
which suggested that histamine may act through an additional With respect to the amounts of cis-UCA used in these prostanoid-independent pathway. studies ( 0·2-200 mg/mouse; Fig. 1a) , it has been estimated Cis-UCA is structurally related to histamine32 and it might previously that the concentration of cis-UCA in non-irradiated be concluded from the experiments with the histamine receptor murine epidermis was 0·2 mg/cm2, with values of 15 mg/cm2
antagonists that cis-UCA bound to histamine receptors. antagonists inhibited the eÂects of histamine, rather than histamine/mouse ( Fig. 1) .
blocked cis-UCA binding to its receptor. The relevance and the magnitude of involvement of histaThis study did not identify keratinocytes as the source of mine in UVB-and cis-UCA-induced systemic suppression of prostanoids in UVB-induced immunosuppression; however, CHS responses and UVB-and cis-UCA-induced prostanoid keratinocytes are the major structural cells of the epidermis production, respectively, was the focus of this study. Experiand trans-UCA is found in the stratum corneum. As the ments with the cis-UCA antibody confirmed that histamine majority of UVB light does not penetrate beyond the acts downstream of cis-UCA in signalling immunosuppression.
epidermis, keratinocytes reside at sites adjacent to cis-UCA Both UVB-and cis-UCA-induced suppression of CHS formation. Furthermore, keratinocytes express H1 and H2 responses was partially reversed by administration of receptor receptors17 and both types of receptor play a role in mediating antagonists to histamine (Fig. 4 ) , which may be released by the response by keratinocytes to cis-UCA and histamine.16 degranulating mast cells31 or by keratinocytes.30 Indeed, this Thus, the need for blockade of both receptor types by cypstudy presents the first direct evidence that histamine receptor roheptadine and cimetidine, respectively, for optimal inhibition antagonists inhibit UVB irradiation-induced suppression of was expected. The source of the bioactive histamine was not systemic CHS responses. In further experiments investigating confirmed. A report of cis-UCA as a mast cell degranulating prostanoid involvement in these responses, the possibility of agent in mice31 led us to hypothesize that cis-UCA directly or additive eÂects of indomethacin, a cyclo-oxygenase inhibitor, indirectly causes mast cell degranulation and contributes to, with histamine receptor antagonists was investigated ( Fig. 6) .
and perhaps is totally responsible for, UVB-induced mast cell The lack of any cumulative eÂects by the combination of degranulation, particularly as mast cells are located in the reagents suggested that the histamine receptor antagonists dermis and at a site to which minimal UVB irradiation inhibited the receipt of stimuli for initiation of synthesis of the transmits. same prostanoids, the production of which was blocked by The mechanism(s) by which skin-derived prostanoids signal indomethacin. Thus, in the whole animal, the prostanoidsystemic suppression of CHS responses and reduce immune associated component of UVB immunosuppression was linked responses to antigens applied to distant body sites is not with the activity of histamine.
known. The vasodilatory eÂects of PGE 2 and PGI 2 33 may The extent of histamine involvement in the mechanallow other immunomodulatory epidermal cytokines access to isms responsible for cis-UCA-induced suppression of CHS the vasculature where they can have systemic eÂects. responses was not clearly determined. Whether suÃcient histaProstanoids have been hypothesized to 'force sequestration mine receptor antagonists and/or indomethacin were present of sensitized eÂector cells in peripheral lymph nodes.3 By at the site of histamine action and/or prostanoid production to be fully eÂective may be an issue. The histamine receptor inhibiting interleukin-12 (IL-12) production, prostanoids may Langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity
